pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Aug 12·1 min read
save

Study finds cancer patients now wait longer for treatment than a decade ago

Aug 12, 2026·read at STAT ↗Negative

A new analysis of more than 2.7 million cancer cases shows that the interval between diagnosis and the start of therapy has grown over the past ten years. The researchers examined records from a national cancer database covering the period from 2012 to 2023 and focused on stage 1 to 3 tumors that were initially considered suitable for surgery.

Across all six cancer types evaluated, patients today experience longer delays before treatment begins compared with a decade ago. The authors point to factors such as the increasing complexity of care pathways, shortages in the medical workforce, and the time required for insurance pre‑authorization as possible contributors.

The findings highlight a growing challenge for oncology providers and may have implications for treatment outcomes, as extended waiting periods can heighten patient anxiety and potentially allow disease progression.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Cancer patients face longer wait times to begin treatment, according to new study”

read at STAT ↗
536 words · retrieved Aug 12
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY
topics
Oncology16Drug ShortageImmunologyMonoclonal AntibodyPsychiatry & CNSVaccine

related stories

  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • 2d agoChutes & Ladders—Legend poaches Novartis vet to boost commercial potentialFierce Biotech
  • 3d agoSionna says good-bye to 46% of staffers, including execBioSpace
  • Sep 8Reeling from past failures, Parkinson's pipeline enters 'era of diversification'BioSpace
  • Aug 31A winner, a loser, and a mid-stage signal from a major cardiology research conferenceSTAT